KYMERA THERAPEUTICS INC (KYMR) Stock Balance Sheet
NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 110.72M | 109.97M | 68.40M | 48.00M | 31.00M | |||
| Marketable Securities | 439.25M | 264.92M | 338.80M | 394.40M | 265.20M | |||
| Receivables | 1.32M | 18.76M | 2.50M | 100.00K | 1.40M | |||
| Other Current Assets | 17.43M | 11.67M | 9.70M | 8.70M | 4.70M | |||
| Total Current Assets | 568.72M | 405.32M | 419.40M | 451.30M | 302.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 99.31M | 101.08M | 22.20M | 21.30M | 20.70M | |||
| Investments And Advances | 361.04M | 61.43M | 152.30M | 125.20M | 162.50M | |||
| Other Non-Current Assets | 5.78M | 7.93M | 9.10M | 8.10M | 1.60M | |||
| Total Non-Current Assets | 466.13M | 170.44M | 183.70M | 154.60M | 184.90M | |||
| TOTAL ASSETS | 1.03B | 575.76M | 603.10M | 605.90M | 487.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.34M | 1.28M | 1.40M | 1.10M | 700.00K | |||
| Accrued Expenses | 37.00M | 35.25M | 29.60M | 25.10M | 12.90M | |||
| Accounts Payable | 6.49M | 7.08M | 4.30M | 4.00M | 4.40M | |||
| Other Current Liabilities | 21.69M | 42.09M | 36.00M | 62.30M | 92.70M | |||
| Total Current Liabilities | 66.53M | 85.69M | 71.30M | 92.50M | 110.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.74M | 1.30M | 1.20M | 1.10M | 600.00K | |||
| Other Non-Current Liabilities | 73.64M | 93.80M | 40.40M | 52.60M | 92.10M | |||
| Total Non-Current Liabilities | 75.38M | 95.10M | 41.70M | 53.80M | 92.70M | |||
| TOTAL LIABILITIES | 141.91M | 180.79M | 113.00M | 146.30M | 203.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -683.86M | -530.75M | -383.80M | -229.00M | -128.80M | |||
| Additional Paid In Capital | 1.57B | 926.27M | 878.90M | 689.30M | 412.80M | |||
| Common Shares | 7.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 1.93M | -552.00K | -4.90M | -700.00K | -100.00K | |||
| Shares Outstanding | 64.75M | 55.59M | 55.00M | 51.50M | 44.50M | |||
| Tangible Book Value per Share | 13.79 | 7.11 | 8.91 | 8.92 | 6.38 | |||
| Total Shareholders' Equity | 892.93M | 394.97M | 490.20M | 459.60M | 283.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.03B | 575.76M | 603.10M | 605.90M | 487.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 8.55 | 4.73 | 5.88 | 4.88 | 2.73 | |||
| Return On Assets (ROA) | -16.18% | -25.52% | -25.67% | -16.54% | -11.22% | |||
| Return On Equity (ROE) | -18.76% | -37.21% | -31.58% | -21.81% | -19.25% | |||
All data in USD , ROIC based on taxRate of 0.21